Related Experiment Video
Updated: Dec 8, 2025

Quantification of Atherosclerosis in Mice
Published on: June 12, 2019
Deletion of NoxO1 limits atherosclerosis development in female mice
Giulia K Buchmann1, Christoph Schürmann1, Tim Warwick1
1Institute for Cardiovascular Physiology, Goethe-University, Theodor-Stern Kai 7, 60590, Frankfurt Am Main, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Rhein Main, Theodor-Stern Kai 7, 60590, Frankfurt Am Main, Germany.
Objective:
Oxidative stress is a risk factor for atherosclerosis. NADPH oxidases of the Nox family produce ROS but their contribution to atherosclerosis development is less clear. Nox2 promotes and Nox4 rather limits atherosclerosis. Although Nox1 with its cytosolic co-factors are largely expressed in epithelial cells, a role for Nox1 for atherosclerosis development was suggested. To further define the role of this homologue, the role of its essential cytosolic cofactor, NoxO1, was determined for atherosclerosis development with the aid of knockout mice.
Methods And Results:
Wildtype (WT) and NoxO1 knockout mice were treated with high fat diet and adeno-associated virus (AAV) overexpressing pro-protein convertase subtilisin/kexin type 9 (PCSK9) to induce hepatic low-density lipoprotein (LDL) receptor loss. As a result, massive hypercholesterolemia was induced and spontaneous atherosclerosis developed within three month. Deletion of NoxO1 reduced atherosclerosis formation in brachiocephalic artery and aortic arch in female but not male NoxO1-/- mice as compared to WT littermates. This was associated with a reduced pro-inflammatory cytokine signature in the plasma of female but not male NoxO1-/- mice. MACE-RNAseq of the vessel did not reveal this signature and the expression of the Nox1/NoxO1 system was low to not detectable.
Conclusions:
The scaffolding protein NoxO1 plays some role in atherosclerosis development in female mice probably by attenuating the global inflammatory burden.
Insights
The scaffolding protein NoxO1 plays a role in atherosclerosis development, particularly in female mice, by reducing inflammation. Deleting NoxO1 decreased atherosclerosis and pro-inflammatory cytokines in female mice.
Area of Science:
- Cardiovascular Research
- Oxidative Stress Biology
- Molecular Medicine
Background:
- Oxidative stress is a known risk factor for atherosclerosis.
- NADPH oxidases (Nox) produce reactive oxygen species (ROS), but their specific roles in atherosclerosis are not fully understood.
- While Nox2 promotes and Nox4 limits atherosclerosis, the contribution of Nox1 and its cofactors, like NoxO1, remains less clear.
Purpose of the Study:
- To investigate the role of the essential cytosolic cofactor NoxO1 in the development of atherosclerosis.
- To define the function of the Nox1/NoxO1 system in cardiovascular disease progression.
Main Methods:
- Utilized wildtype (WT) and NoxO1 knockout mice.
- Induced hypercholesterolemia and atherosclerosis using a high-fat diet and adeno-associated virus (AAV)-mediated PCSK9 overexpression.
- Analyzed atherosclerosis formation in the brachiocephalic artery and aortic arch, and assessed plasma cytokine profiles.
Main Results:
- Deletion of NoxO1 reduced atherosclerosis in female, but not male, mice compared to WT littermates.
- A reduced pro-inflammatory cytokine signature was observed in the plasma of female NoxO1 knockout mice.
- Vessel-based MACE-RNAseq did not confirm this inflammatory signature, and Nox1/NoxO1 system expression was low.
Conclusions:
- The scaffolding protein NoxO1 plays a role in atherosclerosis development, particularly in female mice.
- NoxO1 may attenuate the global inflammatory burden, thereby influencing atherosclerosis progression.
- Further research is needed to fully elucidate the mechanisms by which NoxO1 impacts cardiovascular disease.
More Related Videos
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
06:18An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
Published on: August 13, 2019
Related Concept Videos
Atherosclerosis I: Introduction
X-Inactivation